← Leaderboards
Yow-Pin Lim
Prothera Biologics, Llc
$11,549,675
Attributed
$12,529,006
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,529,006 · 12
By mechanism
R44$10,191,628 · 3
R43$1,799,316 · 7
R21$398,151 · 1
U43$139,911 · 1
Top collaborators
- James F Padbury2 shared
Most similar at Prothera Biologics, Llc
Same institution · by research overlap
- Steven M. Opal$3,663,561
Others in their field
Top investigators on “Plasma”
- David Heimbrook · Leidos Biomedical Research, Inc.$170,532,526
- Barton F Haynes · Duke University$119,611,088
- Paul S. Aisen · Cognition Therapeutics, Inc.$110,079,727
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,527,289
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$85,429,770
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$78,577,996
Research focus
PlasmaProteinsInter-Alpha-InhibitorInflammationAcuteAdultSepsisLifeSmall Business Innovation Research GrantInfantNeonatalLaboratoriesPlayBloodInjuryFutureHigh Risk InfantInfectionDesignMorbidity - Disease RatePremature InfantInflammatory ResponseNeonatal SepsisClinical Research
Grant awards (22)
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis$971,267
R44 · FY2025 · AI · contact PI
Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis$50,184
R43 · FY2025 · HD · contact PI
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis$987,396
R44 · FY2024 · AI · contact PI
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury$2,776,920
R44 · FY2023 · NS · contact PI
Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis$378,272
R43 · FY2023 · HD · contact PI
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis$862,493
R44 · FY2020 · AI · contact PI
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis$1,000,000
R44 · FY2019 · AI · contact PI
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury$941,149
R44 · FY2018 · NS · contact PI
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis$166,522
R44 · FY2018 · AI · contact PI
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury$984,466
R44 · FY2017 · NS · contact PI
Therapeutic Role of Inter-alpha Inhibitors in Wound Healing$224,688
R43 · FY2015 · AR · contact PI
Inter-alpha-inhibitors in Hypoxic-Ischemic Brain Injury$203,226
R43 · FY2014 · NS · contact PI
Rapid detection of neonatal sepsis$250,566
R43 · FY2013 · HD · contact PI
Rapid detection of neonatal sepsis$247,495
R43 · FY2012 · HD · contact PI
THERAPEUTIC USE OF INTER-ALPHA INHIBITOR IN SEPSIS$983,869
R44 · FY2007 · GM · contact PI
Bioprocessing of Plasma Therapeutic Proteins using Sequential Affinity Monolithic$170,547
R43 · FY2007 · GM · contact PI
Inter-alpha Inhibitors in Neonatal Sepsis$184,971
R21 · FY2005 · HD
Inter-alpha Inhibitors in Detecting CNS Cancer$139,911
U43 · FY2005 · CA
THERAPEUTIC USE OF INTER-ALPHA INHIBITOR IN SEPSIS$517,546
R44 · FY2004 · GM
Inter-alpha Inhibitors in Neonatal Sepsis$213,180
R21 · FY2004 · HD
Predictive value of inter-alpha inhibitors in sepsis$131,233
R43 · FY2003 · GM
Therapeutic Use of Inter-alpha Inhibitor in Sepsis$143,105
R43 · FY2002 · GM